Article in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Weimin GuoDepartment of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.ORCID 0000-0003-4318-7154
Laura Carretero SantosDepartment of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
Gar Yee KohNutrition and Foods Program, School of Family & Consumer Sciences, Texas State University, St Marcos, TX, USA.ORCID 0000-0002-2783-1723
Michael MalamyDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.ORCID 0009-0007-5210-1689
Aidan HawleyDepartment of Chemistry, University of South Florida, Tampa, FL, USA.
Hadassah BeachyDepartment of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
Bridget WhelpleyDepartment of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
Junyue WangDepartment of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
Daniel R DempseyDepartment of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.ORCID 0000-0001-6104-0805
Jimmy W CrottDepartment of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.ORCID 0000-0002-3529-8826
Funding
Molecular mechanisms of RNA methyltransferases.R35GM155301 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Daniel R. Dempsey · 2024 to 2026
$1.1M
Training in BioMolecular PharmacologyT32GM159592 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Hui Feng, Venetia Zachariou · 2025 to 2026
$858k
Identifying the active factor of an anti-inflammatory chemopreventive bacteriumR21CA253392 · NCI · TUFTS UNIVERSITY BOSTON · PI CROTT, JIMMY W · 2021 to 2021
Gut bacteria are well known to impact a diverse array of acute and chronic diseases. One mechanism by which gut bacteria can impact health is by modulating inflammation. We and others previously found that membrane components of the gram-negative bacterium
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Identification and characterization of a lipopolysaccharide binding, anti-inflammatory protein from · full record | OpenQuestion